five

Clinical value of turbidity-elimination gout soup combined with external application of traditional chinese medicine to improve the pain and the volume of tophi in patients with gout

收藏
DataCite Commons2021-03-26 更新2024-07-28 收录
下载链接:
https://scielo.figshare.com/articles/dataset/Clinical_value_of_turbidity-elimination_gout_soup_combined_with_external_application_of_traditional_chinese_medicine_to_improve_the_pain_and_the_volume_of_tophi_in_patients_with_gout/14318533/1
下载链接
链接失效反馈
官方服务:
资源简介:
Abstract To analyze the clinical value of turbidity-elimination gout soup combined with external application of traditional Chinese medicine to improve pain and the volume of tophi in patients with gout. A total of 94 patients with gout were selected as the study samples. They were randomly divided into control group treated with colchicine tablets and observation group treated with turbidity-elimination gout soup combined with external application of traditional Chinese medicine. Two groups of patients were compared before and after treatment in terms of pain, volume of tophi, score of TCM symptoms and laboratory indicators. There was no significant difference in NRS score, volume of tophi, redness and swelling of joints, heat and pain and other laboratory indicators between the two groups before treatment (P>0.05); NRS score, tophi, the integral of symptoms and other symptoms, and erythrocyte sedimentation rate, white blood cell count, blood uric acid level and etc. laboratory indexes of patients in the observation group were lower than those of the control group after treatment (P<0.05). Combination will effectively reduce the pain of patients with gout, reduce the volume of tophi, correct clinical symptoms and improve the level of laboratory indicators, with clinical reference and implementation efficiency.

摘要:为分析消浊痛风汤联合中药外敷改善痛风患者疼痛及痛风石(tophi)体积的临床价值,本研究共纳入94例痛风患者作为研究样本,采用随机分组方式将其分为对照组与观察组:对照组予以秋水仙碱片治疗,观察组予以消浊痛风汤联合中药外敷治疗。对比两组患者治疗前后的疼痛程度、痛风石体积、中医症状积分及实验室指标水平。治疗前,两组患者的数字疼痛评分法(NRS)评分、痛风石体积、关节红肿热痛程度及各项实验室指标均无显著统计学差异(P>0.05);治疗后,观察组患者的NRS评分、痛风石体积、症状积分,以及红细胞沉降率、白细胞计数、血尿酸水平等实验室指标均显著低于对照组(P<0.05)。该联合治疗方案可有效缓解痛风患者疼痛、缩小痛风石体积、改善临床症状并优化实验室指标水平,具备较高的临床参考价值与应用可行性。
提供机构:
SciELO journals
创建时间:
2021-03-26
二维码
社区交流群
二维码
科研交流群
商业服务